INTRODUCTION: Iq'mik, a form of smokeless tobacco (ST), is traditionally used by Cup'ik and Yup'ik Eskimo people of western Alaska. Iq'mik is sometimes incorrectly considered to be a healthier alternative to smoking because its ingredients are perceived as "natural." Our chemical characterization of iq'mik shows that iq'mik is not a safe alternative to smoking or other ST use. METHODS: We measured nicotine and pH levels of tobacco and ash used to prepare iq'mik. We also characterized levels of toxins which are known to be present in ST including tobacco-specific nitrosamines (TSNAs) and polycyclic aromatic hydrocarbons (PAHs) using chromatographic separations coupled with isotope dilution mass spectrometry. RESULTS: Nicotine content in the iq'mik tobacco was very high, ranging from 35 to 43 mg/g, with a mean of 39 mg/g. The pH of the iq'mik tobacco-ash mixture was 11, an extremely high level compared with most ST products. High levels of PAHs were seen in the fire-cured tobacco samples with a benzo[a]pyrene level of 87 ng/g. Average TSNA levels in the tobacco were 34, 2,700, and 340 ng/g for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL), N'-nitrosonornicotine (NNN), and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), respectively. CONCLUSIONS: Iq'mik contains high levels of the more easily absorbed unionized nicotine as well as known carcinogenic TSNAs and PAHs. The perception that iq'mik is less hazardous than other tobacco products due to the use of "natural" ingredients is not warranted. This chemical characterization of iq'mik gives a better understanding of the risk of possible adverse health effects of its use.
INTRODUCTION: Iq'mik, a form of smokeless tobacco (ST), is traditionally used by Cup'ik and Yup'ik Eskimo people of western Alaska. Iq'mik is sometimes incorrectly considered to be a healthier alternative to smoking because its ingredients are perceived as "natural." Our chemical characterization of iq'mik shows that iq'mik is not a safe alternative to smoking or other ST use. METHODS: We measured nicotine and pH levels of tobacco and ash used to prepare iq'mik. We also characterized levels of toxins which are known to be present in ST including tobacco-specific nitrosamines (TSNAs) and polycyclic aromatic hydrocarbons (PAHs) using chromatographic separations coupled with isotope dilution mass spectrometry. RESULTS: Nicotine content in the iq'mik tobacco was very high, ranging from 35 to 43 mg/g, with a mean of 39 mg/g. The pH of the iq'mik tobacco-ash mixture was 11, an extremely high level compared with most ST products. High levels of PAHs were seen in the fire-cured tobacco samples with a benzo[a]pyrene level of 87 ng/g. Average TSNA levels in the tobacco were 34, 2,700, and 340 ng/g for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL), N'-nitrosonornicotine (NNN), and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), respectively. CONCLUSIONS: Iq'mik contains high levels of the more easily absorbed unionized nicotine as well as known carcinogenic TSNAs and PAHs. The perception that iq'mik is less hazardous than other tobacco products due to the use of "natural" ingredients is not warranted. This chemical characterization of iq'mik gives a better understanding of the risk of possible adverse health effects of its use.
Authors: Caroline C Renner; Carrie Enoch; Christi A Patten; Jon O Ebbert; Richard D Hurt; Thomas P Moyer; Ellen M Provost Journal: Am J Health Behav Date: 2005 Nov-Dec
Authors: Richard D Hurt; Caroline C Renner; Christi A Patten; Jon O Ebbert; Kenneth P Offord; Darrell R Schroeder; Carrie C Enoch; Leigh Gill; Sarah E Angstman; Thomas P Moyer Journal: J Matern Fetal Neonatal Med Date: 2005-04
Authors: Yan S Ding; Xizheng J Yan; Ram B Jain; Eugene Lopp; Ameer Tavakoli; Gregory M Polzin; Stephen B Stanfill; David L Ashley; Clifford H Watson Journal: Environ Sci Technol Date: 2006-02-15 Impact factor: 9.028
Authors: Christi A Patten; Caroline C Renner; Paul A Decker; Ester O'Campo; Karin Larsen; Carrie Enoch; Kenneth P Offord; Richard D Hurt; Anne Lanier; Judith Kaur Journal: Matern Child Health J Date: 2008-03-14
Authors: Baoyun Xia; Benjamin C Blount; Tonya Guillot; Christina Brosius; Yao Li; Dana M Van Bemmel; Heather L Kimmel; Cindy M Chang; Nicolette Borek; Kathryn C Edwards; Charlie Lawrence; Andrew Hyland; Maciej L Goniewicz; Brittany N Pine; Yang Xia; John T Bernert; B Rey De Castro; John Lee; Justin L Brown; Stephen Arnstein; Diane Choi; Erin L Wade; Dorothy Hatsukami; Gladys Ervies; Angel Cobos; Keegan Nicodemus; Dana Freeman; Stephen S Hecht; Kevin Conway; Lanqing Wang Journal: Nicotine Tob Res Date: 2021-02-16 Impact factor: 4.244
Authors: Stephen B Stanfill; André Luiz Oliveira da Silva; Joseph G Lisko; Tameka S Lawler; Peter Kuklenyik; Robert E Tyx; Elizabeth H Peuchen; Patricia Richter; Clifford H Watson Journal: Food Chem Toxicol Date: 2015-04-28 Impact factor: 6.023
Authors: Tameka S Lawler; Stephen B Stanfill; Liqin Zhang; David L Ashley; Clifford H Watson Journal: Food Chem Toxicol Date: 2013-03-19 Impact factor: 6.023
Authors: Tove K Ryman; Bert B Boyer; Scarlett E Hopkins; Jacques Philip; Beti Thompson; Shirley A A Beresford; Kenneth E Thummel; Melissa A Austin Journal: Ethn Health Date: 2017-01-24 Impact factor: 2.772
Authors: Christie A Flanagan; Kathryn R Koller; Abbie W Wolfe; Timothy K Thomas; Neal L Benowitz; Caroline C Renner; Christine Hughes; Dorothy K Hatsukami; Carrie Bronars; Neil J Murphy; Gretchen Day; Paul A Decker; Christi A Patten Journal: Nicotine Tob Res Date: 2016-05-17 Impact factor: 4.244
Authors: Christi A Patten; Oluwole Fadahunsi; Marcelo M K Hanza; Christina A Smith; Paul A Decker; Rahnia Boyer; Laura Ellsworth; Tabetha A Brockman; Christine A Hughes; Carrie A Bronars; Kenneth P Offord Journal: Nicotine Tob Res Date: 2014-02-14 Impact factor: 4.244